Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Cancer|September 21, 2006
Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102)Susan E Krown, Donna Niedzwiecki, Wen-Jen Hwu, et al.Leukemia Research|August 10, 2016
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patientsDavid J Dorer, Ronald K Knickerbocker, Michele Baccarani, et al.Melanoma Research|February 17, 2005
Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer InstituteKenneth A Katz, Eric Jonasch, F Stephen Hodi, et al.Archives of Dermatology|June 12, 2002
Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanomaHensin Tsao, Peri Millman, Gerald P Linette, et al.Cancer|June 20, 2007
Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysisDaan P Livestro, Emily M Kaine, James S Michaelson, et al.Cancer Research|May 8, 2013
Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPCChi Luo, Jinghao Sheng, Miaofen G Hu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial CarcinomaAmit M Oza, Sandro Pignata, Andres Poveda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial dataKerry L Kilbridge, Bernard F Cole, John M Kirkwood, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study GroupAgop Y Bedikian, Michael Millward, Hubert Pehamberger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other BiomarkersSuzanne George, Margaret von Mehren, Jonathan A Fletcher, et al.Pageof 4